ATE365037T1 - Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens - Google Patents

Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens

Info

Publication number
ATE365037T1
ATE365037T1 AT02700095T AT02700095T ATE365037T1 AT E365037 T1 ATE365037 T1 AT E365037T1 AT 02700095 T AT02700095 T AT 02700095T AT 02700095 T AT02700095 T AT 02700095T AT E365037 T1 ATE365037 T1 AT E365037T1
Authority
AT
Austria
Prior art keywords
bottle containing
oxaliplatin solution
containing oxaliplatin
cytostatic
activity
Prior art date
Application number
AT02700095T
Other languages
English (en)
Inventor
Houssam Ibrahim
Ross Blundell
Martin Gray
Original Assignee
Debiopharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4513891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE365037(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Debiopharm Sa filed Critical Debiopharm Sa
Application granted granted Critical
Publication of ATE365037T1 publication Critical patent/ATE365037T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/282—Platinum compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT02700095T 2001-03-02 2002-03-04 Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens ATE365037T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3892001 2001-03-02

Publications (1)

Publication Number Publication Date
ATE365037T1 true ATE365037T1 (de) 2007-07-15

Family

ID=4513891

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02700095T ATE365037T1 (de) 2001-03-02 2002-03-04 Verwendung eines eine oxaliplatinlösung beinhaltenden fläschchens

Country Status (10)

Country Link
US (2) US20040220078A1 (de)
EP (1) EP1368022B1 (de)
AT (1) ATE365037T1 (de)
DE (2) DE60220766T2 (de)
DK (1) DK1368022T3 (de)
ES (1) ES2287238T3 (de)
FI (1) FI7753U1 (de)
PT (1) PT1368022E (de)
SI (1) SI1368022T1 (de)
WO (1) WO2002069959A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004063764A1 (de) * 2004-12-29 2006-07-13 Hexal Ag Kunststoff-Flasche für Oxaliplatin
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
MX2017000083A (es) 2014-06-23 2017-05-30 Placon Therapeutics Inc Compuestos de platino, composiciones y usos de estos.
PT3865484T (pt) 2015-07-07 2024-01-30 H Lundbeck As Inibidor da pde9 com esqueleto de imidazo pirazinona para tratamento de doenças periféricas
MX2018016127A (es) 2016-07-06 2019-05-30 Imara Inc Inhibidores de pde9 para el tratamiento de enfermedades perifericas.
ES2969895T3 (es) 2017-05-26 2024-05-23 Cardurion Pharmaceuticals Inc Métodos para obtener y usar inhibidores de PDE9
WO2019226944A1 (en) 2018-05-25 2019-11-28 Imara Inc. Monohydrate and crystalline forms of 6-[(3s,4s)-4-methyl-1- (pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl- 7h-imid azo [1,5- a] pyrazin-8-one

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4566600A (en) * 1984-07-05 1986-01-28 Owens-Illinois, Inc. Plastic container
CA1232215A (en) * 1984-10-23 1988-02-02 Maud Frizon Sphereoidal bottle with stopper
IL114852A (en) * 1994-08-08 2000-02-29 Debiopharm Sa Pharmaceutically stable preparation of oxaliplatinum
GB9804013D0 (en) 1998-02-25 1998-04-22 Sanofi Sa Formulations
EP1121117B1 (de) * 1998-10-14 2002-06-05 Debiopharm S.A. Verpackung eines oxaliplatinhaltigen arzneimittels

Also Published As

Publication number Publication date
FI7753U1 (fi) 2008-01-30
FIU20070189U0 (fi) 2007-05-07
DE60220766D1 (de) 2007-08-02
EP1368022A1 (de) 2003-12-10
EP1368022B1 (de) 2007-06-20
WO2002069959A1 (fr) 2002-09-12
PT1368022E (pt) 2007-10-01
DE20221679U1 (de) 2006-11-23
SI1368022T1 (sl) 2007-10-31
ES2287238T3 (es) 2007-12-16
US20040220078A1 (en) 2004-11-04
DK1368022T3 (da) 2007-10-01
US20080108697A1 (en) 2008-05-08
DE60220766T2 (de) 2008-03-06

Similar Documents

Publication Publication Date Title
FI7753U1 (fi) Laite oksaliplatiiniliuoksen pakkaamiseksi
DE60232017D1 (de) Flüssige zusammensetzung aus faktor vii polypeptiden
UY26704A1 (es) Nueva composición farmacéutica
UY27329A1 (es) Champues con alcohol de behenilo
AU7485301A (en) Methods for refolding proteins containing free cysteine residues
PT723437E (pt) Preparacao farmaceutica por unidades multiplas contendo um inibidor da bomba de protoes
NO20025355L (no) Farmasöytisk preparat som omfatter en faktor VIIA og en faktor XIII
IL172835A0 (en) A composition for stabilizing active protein ingredients in pharmaceutical composition containing at least 2 amino acids
CY1113854T1 (el) Αναστολεις κυτταρικου πολλαπλασιασμου που περιεχουν αντισωμα εναντι της γλυπικανης 3
ATE295829T1 (de) Verwendung von biologisch aktivem glas zum schneiden von biologisch aktivem glas
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
BR0308429A (pt) Aroilpiridinonas monocìclicas como agentes antiinflamatórios
MXPA03006841A (es) 4-fluoro-n-indan-2-il-benzamida y su uso como producto farmaceutico.
IS6658A (is) Ný efnasambönd
CO5580776A2 (es) Formulacion farmaceutica estable en solucion de oxaliplatino
DE69404675D1 (de) Pharmazeutische zusammensetzung zur intranasalen verabreichung von hydroxocobalamin
ATE333290T1 (de) Zusammensetzungen für die freisetzung von protein auf dem pulmonalen weg
BRPI0410679A (pt) fórmulas de proteìna lìquida estabilizada em conteiners farmacêuticos cobertos
DK1644504T3 (da) Faktor VII- eller -VIIA-Gla-domænevarianter
WO2003012050A3 (en) Mitochondrial genome replenishment
BR0213298A (pt) formulações com alta concentração de proteìna e processo de fabricação
ATE406903T1 (de) Zusammensetzung und ihre verwendungszwecke zur bekämpfung von kater
SE0102716D0 (sv) Novel compounds
PT95212A (pt) Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide
DE602004031039D1 (de) Viruzide wirkungen von einer zubereitung enthaltend cetylpyridiniumchlorid und zitronensäure

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1368022

Country of ref document: EP

RZN Patent revoked